gi-hepatology
Mumtaz Score for 30-Day Readmission in Cirrhosis
Information page: 30-day readmission after a cirrhosis admission. There is no validated 'Mumtaz score'; published readmission models discriminate only modestly.
Used in: Liver Disease & Cirrhosis
References
- Koola JD, et al. Predicting 30-day hospital readmission risk in a national cohort of patients with cirrhosis. Dig Dis Sci. 2020;65(4):1003–1031.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Spironolactone (Ascites / Cirrhosis) · Aldosterone Antagonist / Potassium-Sparing Diuretic
- Furosemide (Ascites / Cirrhosis) · Loop Diuretic
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.